The global galacto-oligosaccharides market is anticipated to exhibit a considerable CAGR of 8.0% during the forecast period (2020-2026). Galacto-oligosaccharides is non-digestible oligosaccharides with prebiotic properties that can be incorporated into a wide number of products. Galacto?oligosaccharides impart direct bacteriostatic or bacteriocidal antimicrobial effects in the body of the infant. Galacto?oligosaccharides prohibit the growth of streptococcus agalactiae, which is a key cause of invasive bacterial infections in newborns. The proper feeding of the infant with galacto?oligosaccharides reduces the risk of pneumonia, septicemia, and meningitis in infants. Several studies have revealed the effects of galacto?oligosaccharides enable the newborn to fight against the emerging antibiotic-resistance crisis.

A full Report of Global Galacto-Oligosaccharides Market Available at: https://www.omrglobal.com/industry-reports/galacto-oligosaccharides-market

For instance, a research collaboration within the Dutch public-private partnership CarboHealth, coordinated by the Carbohydrate Competence Center had revealed that the gut microbiota composition of infants fed traditional infant formula lacking oligosaccharides was very different from that of breastfed infants. Nowadays, infant formula is commonly supplemented with oligosaccharides, such as galacto-oligosaccharides (GOS) and/or fructo-oligosaccharides (FOS) to support the establishment of healthy gut microbiota in formula-fed infants. AIDP Inc., Zuchem, Inc., BASF SE, DuPont de Nemours, Inc., Glycosyn LLC, and so on are the major player that is offering infant formulation of galacto-oligosaccharides. The high adoption of galacto-oligosaccharides in infant formulations is anticipated to drive the growth of the global market.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/galacto-oligosaccharides-market

Market Coverage

• The market number available for – 2018-2026-
• Base year- 2018
• Forecast period- 2019-2026
• Segment Covered- By Product Type, By Application
• Regions Covered- North America, Europe, Asia-Pacific, Rest of the World
• Competitive Landscape- Nestle S.A., Zuchem, Inc., BASF SE, DuPont de Nemours, Inc., Elicityl SA,

Key questions addressed by the report

• What is the market growth rate?
• Which segment/region dominates the market in the base year?
• Which segment/region will project the fastest growth in the market?
• How COVID-19 impacted the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Galacto-Oligosaccharides Market report Segment

By Application

• Infant Formula
• Dietary Supplements
• Functional Food & Beverage

Global Galacto-Oligosaccharides Market report Segment

North America

• United States
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle-East, Africa

Company Profiles

• Abbott Laboratories
• AIDP, Inc.
• BASF SE
• Clasado Biosciences
• DuPont de Nemours, Inc.
• Fonterra Co-operative Group, Ltd.
• Glycosyn LLC
• Ingredion Inc.
• Kerry Group Plc
• Nestle S.A.
• Nissin Sugar Co., Ltd.
• Olygose SAS
• Royal FrieslandCampina N.V.
• Taiwan Fructose Co., Ltd.
• Vitalus Nutrition, Inc.
• Yakult Pharmaceutical Industry Co., Ltd.
• ZuChem, Inc.

For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/galacto-oligosaccharides-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404